FDA testing indicates Zantac does not form carcinogen in users

The U.S. Food and Drug Administration said on Friday that tests it ran to simulate what happens to the commonly used heartburn drug Zantac in users' stomachs suggest it does not cause cancer-causing chemicals to form.